Finance

Lists
DHER34:BVMF
Danaher Corporation Bdr
39,84 R$
+1,22%
(+0,48) 1D
13 հոկ, 10:30:08 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for DHER34...
Open
39,84 R$
High
39,84 R$
Low
39,84 R$
Mkt. cap
154,38 մլրդ
Avg. vol.
2,37 հզր
Volume
1,00
52-wk high
45,87 R$
52-wk low
27,94 R$
Shares outstanding
702,99 մլն
No. of employees
59 հզր
Open
39,84 R$
High
39,84 R$
Low
39,84 R$
Mkt. cap
154,38 մլրդ
Avg. vol.
2,37 հզր
Volume
1,00
52-wk high
45,87 R$
52-wk low
27,94 R$
Shares outstanding
702,99 մլն
No. of employees
59 հզր
News stories
From web sources and news partners
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing. The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr
CEORainer M. Blair
Employees59 հզր
Founded1969
Headquarters-
Sector-
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
6,05 մլրդ
6,84 մլրդ
5,95 մլրդ
6,26 մլրդ
Cost of goods sold
2,53 մլրդ
2,86 մլրդ
2,36 մլրդ
2,61 մլրդ
Cost of revenue
2,53 մլրդ
2,86 մլրդ
2,36 մլրդ
2,61 մլրդ
Research and development expenses
378,00 մլն
438,00 մլն
387,00 մլն
412,00 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,89 մլրդ
2,03 մլրդ
1,84 մլրդ
2,01 մլրդ
Operating expense
2,27 մլրդ
2,46 մլրդ
2,23 մլրդ
2,42 մլրդ
Total operating expenses
4,80 մլրդ
5,32 մլրդ
4,59 մլրդ
5,03 մլրդ
Operating income
1,26 մլրդ
1,52 մլրդ
1,36 մլրդ
1,24 մլրդ
Other non operating income
-
-87,00 մլն
-
-
EBT including unusual items
1,08 մլրդ
1,37 մլրդ
1,24 մլրդ
1,08 մլրդ
EBT excluding unusual items
1,19 մլրդ
1,39 մլրդ
1,33 մլրդ
1,19 մլրդ
Income tax expense
168,00 մլն
190,00 մլն
206,00 մլն
208,00 մլն
Effective tax rate
15,61%
13,84%
16,68%
19,29%
Other operating expenses
-
-
-
-
Net income
908,00 մլն
1,20 մլրդ
1,03 մլրդ
870,00 մլն
Net profit margin
15,00%
17,51%
17,29%
13,89%
Earnings per share
1,89
2,23
2,06
1,94
Interest and investment income
3,00 մլն
13,00 մլն
27,00 մլն
61,00 մլն
Interest expense
-67,00 մլն
-55,00 մլն
-63,00 մլն
-107,00 մլն
Net interest expenses
-64,00 մլն
-42,00 մլն
-36,00 մլն
-46,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,88 մլրդ
2,14 մլրդ
1,99 մլրդ
1,90 մլրդ
Gain or loss from assets sale
-9,00 մլն
9,00 մլն
-
-
AI content may include mistakes. Learn more
Google Apps